Drugs / cinobufotalin
cinobufotalin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03189992 Background | Jan 2014 → Aug 2017 | small intestine cancer | Shanghai University of Traditional Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cinobufotalin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03189992 ↗ |
| Known as | Cinobufagin metabolite m-2 | ChEMBL registry synonym — accepted as the source's own label CHEMBL517341 ↗ |
| Known as | cinobufotalin injection | “Drug: cinobufotalin injection” NCT03189992 ↗ |
| Known as | NSC-90326 | ChEMBL registry synonym — accepted as the source's own label CHEMBL517341 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “an effective Chinese preparation to treat malignant tumor.” NCT03189992 ↗ |